S&P 500 7,394 -0.66% Nasdaq 24,848 -2.59% Dow Jones 52,046 +0.40% FTSE 100 10,782 +2.44% DAX 25,361 +2.07% Nikkei 225 64,931 -1.96% Hang Seng 25,207 +0.26% WTI Crude 83.17 -4.22% Gold 4,078 -1.66% US 10-Year Treasury Yield 4.647 +0.41% S&P 500 7,394 -0.66% Nasdaq 24,848 -2.59% Dow Jones 52,046 +0.40% FTSE 100 10,782 +2.44% DAX 25,361 +2.07% Nikkei 225 64,931 -1.96% Hang Seng 25,207 +0.26% WTI Crude 83.17 -4.22% Gold 4,078 -1.66% US 10-Year Treasury Yield 4.647 +0.41%

LATEST

Russia’s Sberbank Sets December Deadline for Crypto Buildout: Report●Africa’s data centre capacity exceeds 500 MW with 890 MW in pipeline – Report●Circle Buys IBM Blockchain Patent Estate—And Becomes America's Biggest Holder●CME launches single stock futures enabling investors to trade SpaceX, Micron 23 hours a day●5-star analyst aggressively resets Intel stock price target after earnings●ICAI’s first International Conference Europe held in Luxembourg●TotalEnergies to Appeal Court Order to Adapt Business to Climate Goals●Should you get paid to care for a family member?●Russia’s Sberbank Sets December Deadline for Crypto Buildout: Report●Africa’s data centre capacity exceeds 500 MW with 890 MW in pipeline – Report●Circle Buys IBM Blockchain Patent Estate—And Becomes America's Biggest Holder●CME launches single stock futures enabling investors to trade SpaceX, Micron 23 hours a day●5-star analyst aggressively resets Intel stock price target after earnings●ICAI’s first International Conference Europe held in Luxembourg●TotalEnergies to Appeal Court Order to Adapt Business to Climate Goals●Should you get paid to care for a family member?●

Asia

Hedge fund bets on rising US healthcare stocks near 5-year high, Goldman says

Markets-Economic Times · 1h ago · 🇮🇳 India

Hedge fund bets on rising US healthcare stocks near 5-year high, Goldman says

Hedge funds are actively enhancing their stakes in healthcare stocks, reflecting a significant trend in market behavior. With a notable surge in interest from both speculators and specialized funds, this sector is ripe for investment. The infusion of artificial intelligence into drug discovery is revolutionizing research capabilities, while the Food and Drug Administration's expedited approval processes further boost investor confidence.

Read the full story at Markets-Economic Times →

More Asia

Global markets: Shein will struggle to justify up to $50 billion Hong Kong IPO valuation

Markets-Economic Times · 1h ago

Tata Power board okays raising Rs 4,500 cr via NCDs

Markets-Economic Times · 1h ago

Government engagement with AI creates more uncertainty for investors, Bridgewater CIOs warn

Latest News · 1h ago

Crude tumbles as US-Iran pause eases pressure, but risks to India’s oil supply remain

mint - markets · 1h ago